Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding
Mother-to-child-transmission rates of HIV in the absence of any intervention range between 20 and 45%. However, the provision of antiretroviral drugs (ARVs) during pregnancy, delivery and breastfeeding can reduce HIV transmission to less than 2%. Physiological changes during pregnancy can influence...
Saved in:
Main Authors: | Adeniyi Olagunju, Andrew Owen, Tim R. Cressey |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84867567023&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/51353 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding
by: Olagunju A., et al.
Published: (2017) -
Pharmacokinetic optimization of antiretroviral therapy in pregnancy
by: Kajal Buckoreelall, et al.
Published: (2018) -
Pharmacogenetics and the prevention of mother-to-child transmission of HIV
by: Tim R. Cressey, et al.
Published: (2018) -
The role of formulation on the pharmacokinetics of antiretroviral drugs
by: Diane Et Bastiaans, et al.
Published: (2018) -
Efavirenz pharmacokinetics during pregnancy and infant washout
by: Regis Kreitchmann, et al.
Published: (2019)